img

Transfection Technologies Market Status and Trend Analysis 2017-2034 (COVID-19 Version)


Published on: 2024-01-04 | No of Pages : 138 | Industry : Life & Medical

Publisher : 9 | Format : PDF

Transfection Technologies Market Status and Trend Analysis 2017-2034 (COVID-19 Version)

Summary

Further key aspects of the report indicate that
Chapter 1Research ScopeProduct Definition, Type, End-Use & Methodology
Chapter 2Global Industry Summary
Chapter 3Market Dynamics
Chapter 4Global Market Segmentation by region, type and End-Use
Chapter 5North America Market Segmentation by region, type and End-Use
Chapter 6Europe Market Segmentation by region, type and End-Use
Chapter 7Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8South America Market Segmentation by region, type and End-Use
Chapter 9Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10Market Competition by Companies
Chapter 11Market forecast and environment forecast.
Chapter 12Industry Summary.

The global Transfection Technologies market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.


Based on the type of product

the global Transfection Technologies market segmented into
Lipofection
Electroporation
Nucleofection
Others

Based on the end-use

the global Transfection Technologies market classified into
Research Centers & Academic/Government Institutes
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others

Based on geography

the global Transfection Technologies market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are


Bio-Rad
Polyplus Transfection
MaxCyte
Promega Corporation
Thermo Fisher Scientific
Affymetrix
Agilent Technologies
Altogen Biosystems
Boca Scientific
Chemicell
CytoPulse
Clontech
Deliverics
GE Healthcare Life Sciences
IBA GmbH
Lonza
Inovio Pharmaceuticals
Merck KGaA
Miltenyi Biotec
Oz Biosciences

Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL TRANSFECTION TECHNOLOGIES INDUSTRY
2.1 Summary about Transfection Technologies Industry
2.2 Transfection Technologies Market Trends
2.2.1 Transfection Technologies Production & Consumption Trends
2.2.2 Transfection Technologies Demand Structure Trends
2.3 Transfection Technologies Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Lipofection
4.2.2 Electroporation
4.2.3 Nucleofection
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Research Centers & Academic/Government Institutes
4.3.2 Hospitals & Clinics
4.3.3 Pharmaceutical & Biotechnology Companies
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Lipofection
5.2.2 Electroporation
5.2.3 Nucleofection
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Research Centers & Academic/Government Institutes
5.3.2 Hospitals & Clinics
5.3.3 Pharmaceutical & Biotechnology Companies
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Lipofection
6.2.2 Electroporation
6.2.3 Nucleofection
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Research Centers & Academic/Government Institutes
6.3.2 Hospitals & Clinics
6.3.3 Pharmaceutical & Biotechnology Companies
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Lipofection
7.2.2 Electroporation
7.2.3 Nucleofection
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Research Centers & Academic/Government Institutes
7.3.2 Hospitals & Clinics
7.3.3 Pharmaceutical & Biotechnology Companies
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Lipofection
8.2.2 Electroporation
8.2.3 Nucleofection
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Research Centers & Academic/Government Institutes
8.3.2 Hospitals & Clinics
8.3.3 Pharmaceutical & Biotechnology Companies
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Lipofection
9.2.2 Electroporation
9.2.3 Nucleofection
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Research Centers & Academic/Government Institutes
9.3.2 Hospitals & Clinics
9.3.3 Pharmaceutical & Biotechnology Companies
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Bio-Rad
10.1.2 Polyplus Transfection
10.1.3 MaxCyte
10.1.4 Promega Corporation
10.1.5 Thermo Fisher Scientific
10.1.6 Affymetrix
10.1.7 Agilent Technologies
10.1.8 Altogen Biosystems
10.1.9 Boca Scientific
10.1.10 Chemicell
10.1.11 CytoPulse
10.1.12 Clontech
10.1.13 Deliverics
10.1.14 GE Healthcare Life Sciences
10.1.15 IBA GmbH
10.1.16 Lonza
10.1.17 Inovio Pharmaceuticals
10.1.18 Merck KGaA
10.1.19 Miltenyi Biotec
10.1.20 Oz Biosciences
10.2 Transfection Technologies Sales Date of Major Players (2017-2020e)
10.2.1 Bio-Rad
10.2.2 Polyplus Transfection
10.2.3 MaxCyte
10.2.4 Promega Corporation
10.2.5 Thermo Fisher Scientific
10.2.6 Affymetrix
10.2.7 Agilent Technologies
10.2.8 Altogen Biosystems
10.2.9 Boca Scientific
10.2.10 Chemicell
10.2.11 CytoPulse
10.2.12 Clontech
10.2.13 Deliverics
10.2.14 GE Healthcare Life Sciences
10.2.15 IBA GmbH
10.2.16 Lonza
10.2.17 Inovio Pharmaceuticals
10.2.18 Merck KGaA
10.2.19 Miltenyi Biotec
10.2.20 Oz Biosciences
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Transfection Technologies Product Type Overview
Table Transfection Technologies Product Type Market Share List
Table Transfection Technologies Product Type of Major Players
Table Brief Introduction of Bio-Rad
Table Brief Introduction of Polyplus Transfection
Table Brief Introduction of MaxCyte
Table Brief Introduction of Promega Corporation
Table Brief Introduction of Thermo Fisher Scientific
Table Brief Introduction of Affymetrix
Table Brief Introduction of Agilent Technologies
Table Brief Introduction of Altogen Biosystems
Table Brief Introduction of Boca Scientific
Table Brief Introduction of Chemicell
Table Brief Introduction of CytoPulse
Table Brief Introduction of Clontech
Table Brief Introduction of Deliverics
Table Brief Introduction of GE Healthcare Life Sciences
Table Brief Introduction of IBA GmbH
Table Brief Introduction of Lonza
Table Brief Introduction of Inovio Pharmaceuticals
Table Brief Introduction of Merck KGaA
Table Brief Introduction of Miltenyi Biotec
Table Brief Introduction of Oz Biosciences
Table Products & Services of Bio-Rad
Table Products & Services of Polyplus Transfection
Table Products & Services of MaxCyte
Table Products & Services of Promega Corporation
Table Products & Services of Thermo Fisher Scientific
Table Products & Services of Affymetrix
Table Products & Services of Agilent Technologies
Table Products & Services of Altogen Biosystems
Table Products & Services of Boca Scientific
Table Products & Services of Chemicell
Table Products & Services of CytoPulse
Table Products & Services of Clontech
Table Products & Services of Deliverics
Table Products & Services of GE Healthcare Life Sciences
Table Products & Services of IBA GmbH
Table Products & Services of Lonza
Table Products & Services of Inovio Pharmaceuticals
Table Products & Services of Merck KGaA
Table Products & Services of Miltenyi Biotec
Table Products & Services of Oz Biosciences
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Transfection Technologies Market Forecast (Million USD) by Region 2021f-2026f
Table Global Transfection Technologies Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Transfection Technologies Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Transfection Technologies Market Forecast (Million USD) Share by Demand 2021f-2026f